NDC11 27505000601
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 27505-0006-01 | 27505-0006 |
| 27505-0006-1 | 27505-0006 |
| 27505-006-01 | 27505-006 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ONAPGO | APOMORPHINE HYDROCHLORIDE | MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc | f3552b6e-5ae7-4993-aa1a-e399c4a7080a | 2026-10-05 | Warnings, Adverse reactions | 27505-006-01 27505-006 27505000601 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.